618
Participants
Start Date
October 16, 2023
Primary Completion Date
August 11, 2025
Study Completion Date
August 11, 2025
idecabtagene vicleucel
Specified dose on specified days
Lenalidomide
Specified dose on specified days
Fludarabine
Specified dose on specified days
Cyclophosphamide
Specified dose on specified days
Local Institution - 0083, Anderlecht
Local Institution - 0090, Vienna
Local Institution - 0084, Brussels
Local Institution - 0144, Brussels
Local Institution - 0007, Camperdown
Local Institution - 0004, Melbourne
Local Institution - 0006, Melbourne
Local Institution - 0008, Melbourne
Local Institution - 0005, Brisbane
Local Institution - 0070, Odense
Local Institution - 0089, Salzburg
Local Institution - 0011, Murdoch
Columbia University Irving Medical Center, New York
Local Institution - 0062, Chaïdári
Institut Paoli-Calmettes, Marseille
Local Institution - 0132, Philadelphia
Local Institution - 0064, Rozzano
Local Institution - 0076, Hamburg
Local Institution - 0063, Pátrai
Local Institution - 0021, Madrid
Novant Health Cancer Institute - Elizabeth, Charlotte
Local Institution - 0121, Atlanta
Local Institution - 0104, Atlanta
Local Institution - 0012, Pamplona
Local Institution - 0056, Haifa
Institut Universitaire du Cancer Toulouse - Oncopole - CHU de TOULOUSE, Toulouse
AdventHealth Orlando, Orlando
Local Institution - 0047, Pessac
Local Institution - 0013, Salamanca
Local Institution - 0065, Bologna
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
Centre Hospitalier Universitaire de Nantes - L' Hopital l'hôtel-Dieu, Nantes
Local Institution - 0115, Essen
Hospital Universitari i Politecnic La Fe, Valencia
Ascension Providence Hospital, Southfield
Local Institution - 0073, Cologne
M Health Fairview Clinics and Surgery Center, Minneapolis
Chonnam National University Hwasun Hospital, Hwasun
Hopital Claude Huriez - CHU de Lille, Lille
Washington University School of Medicine, St Louis
Washington University School of Medicine, St Louis
Local Institution - 0072, Heidelberg
Local Institution - 0046, Pierre-Bénite
Local Institution - 0082, Paris
Local Institution - 0031, Paris
Local Institution - 0109, Houston
University of Texas MD Anderson Cancer Center, Houston
Local Institution - 0124, Austin
Colorado Blood Cancer Institute, Denver
Local Institution - 0029, Poitiers
Local Institution - 0078, Ulm
Local Institution - 0131, Los Angeles
Local Institution - 0077, Nuremberg
Local Institution - 0126, Orange
Henri Mondor Hospital, Créteil
Local Institution - 0028, Villejuif
Local Institution - 0113, Sacramento
Local Institution - 0074, Würzburg
Local Institution - 0058, Petah Tikva
Local Institution - 0057, Ramat Gan
Local Institution - 0088, Tel Aviv
Local Institution - 0055, Beersheba
Local Institution - 0059, Jerusalem
Yale University School of Medicine, New Haven
Local Institution - 0151, Boston
Local Institution - 0133, Edmonton
Local Institution - 0001, Hamilton
Local Institution - 0134, Montreal
Local Institution - 0087, Leipzig
Local Institution - 0079, Dresden
Local Institution - 0061, Athens
Local Institution - 0060, Thessaloniki
Local Institution - 0066, Roma
Nagoya City University Hospital, Nagoya
Hokkaido University Hospital, Sapporo
Hyogo Medical University Hospital, Nishinomiya
Kanazawa University Hospital, Kanazawa
Local Institution - 0085, Isehara
Japanese Red Cross Medical Center, Shibuya-ku
Chiba University Hospital, Chiba
Kyushu University Hospital, Fukuoka
Okayama University Hospital, Okayama
Local Institution - 0071, Shimotsuke
Local Institution - 0069, Oslo
Local Institution - 0027, Lublin
Local Institution - 0095, Warsaw
Local Institution - 0023, Warsaw
Local Institution - 0022, Gliwice
Local Institution - 0026, Gdansk
Local Institution - 0024, Poznan
Local Institution - 0091, Bucharest
Seoul National University Hospital, Seoul
Local Institution - 0038, Seoul
Local Institution - 0043, Seoul
Asan Medical Center, Seoul
Local Institution - 0020, Badalona
Local Institution - 0017, L'Hospitalet Del Llobregat
Hospital Clínic de Barcelona, Barcelona
Local Institution - 0093, Birmingham
Local Institution - 0080, London
Local Institution - 0094, London
Lead Sponsor
Collaborators (2)
Bristol-Myers Squibb
INDUSTRY
2seventy bio
INDUSTRY
Celgene
INDUSTRY